Business ❯ Corporate Governance ❯ Investor Relations

Financial Reporting

Earnings Guidance Earnings Announcements Market Performance Misleading Statements Material Misstatements Earnings Reports Market Reactions Earnings Releases Risk Management Advertising Revenue

Boston Scientific Investors Urged to Seek Lead Plaintiff Role in Securities Suit

The outreach highlights claims that Boston Scientific overstated the health of its U.S. electrophysiology business.

Medpace Faces Securities Class Action Over Alleged Backlog Misstatements After Book-to-Bill Miss

Pinterest Investors Face May 29 Deadline to Seek Lead Role in Securities Class Action

Gemini Space Station Investors Face May 18 Deadline in SDNY Securities Class Action

Rocket Lab Adds Three iQPS Electron Launches, Extending a Key Customer Partnership

Oddity Tech Hit With Securities Suits After Ad-Algorithm Disruption and 49% Stock Plunge

Law Firms Urge Gartner Investors Before Lead‑Plaintiff Deadline in Contract‑Value Growth Suit

Alight Investors Pressed to Seek Lead Role in New Securities Class Action by May 15

Investor Lawsuits Target Monday.com Over Growth Claims as Firms Seek Lead Plaintiff

PayPal Investors Face April 20 Deadline in Securities Class Action Over Growth Claims

Securities Fraud Class Action Filed Against Grocery Outlet With May 15 Investor Deadline

Eos Energy Hit With Securities Suit Over Manufacturing Disclosures as Investors Face May 5 Deadline

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

Gartner Investors Courted to Lead Securities Class Action as May 18 Deadline Nears

Lucid Diagnostics Sets Q4 Record as VA Contract Validates Pricing and Eyes Medicare Policy

New Kyndryl Class Action Filing Expands Investor Window, Alleges Inflated Cash Flow

Lakeland Industries Investors Face April 24 Deadline to Seek Lead Role in Securities Class Action

Gartner Securities Class Action Spurs Race for Lead Plaintiff Before May 18

Collegium to Acquire AZSTARYS for $650 Million, Adding Second ADHD Medicine

Agilon Health Investors Face March 2 Deadline in Securities Class Action Over 2025 Guidance